Validation of Acute Myocardial Infarction (AMI) in the FDA’s Mini-Sentinel Distributed Database
| dc.contributor.author | Cutrona, Sarah L | |
| dc.contributor.author | Toh, Darren | |
| dc.contributor.author | Iyer, Aarthi | |
| dc.contributor.author | Foy, Sarah | |
| dc.contributor.author | Cavagnaro, Elizabeth | |
| dc.contributor.author | Forrow, Susan | |
| dc.contributor.author | Goldberg, Robert J. | |
| dc.contributor.author | Gurwitz, Jerry H. | |
| dc.date | 2022-08-11T08:08:12.000 | |
| dc.date.accessioned | 2022-08-23T15:46:10Z | |
| dc.date.available | 2022-08-23T15:46:10Z | |
| dc.date.issued | 2011-05-20 | |
| dc.date.submitted | 2011-08-05 | |
| dc.identifier.doi | 10.13028/p3ce-8e74 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/27695 | |
| dc.description.abstract | The Food and Drug Administration’s (FDA) Mini-Sentinel is a pilot program that aims to conduct active surveillance to detect and refine safety signals that emerge for marketed medical products. The purpose of this Mini-Sentinel AMI Validation project was to: (a) develop and design an abstraction and adjudication process to use when full text medical record review is required to confirm a coded diagnosis; and (b) to test this approach by validating a code algorithm for acute myocardial infarction (AMI). | |
| dc.format | youtube | |
| dc.language.iso | en_US | |
| dc.rights | Copyright the Author(s) | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/ | |
| dc.subject | Biostatistics | |
| dc.subject | Systems Biology | |
| dc.title | Validation of Acute Myocardial Infarction (AMI) in the FDA’s Mini-Sentinel Distributed Database | |
| dc.type | Poster | |
| dc.identifier.legacyfulltext | https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1016&context=cts_retreat&unstamped=1 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/cts_retreat/2011/posters/2 | |
| dc.identifier.contextkey | 2135186 | |
| refterms.dateFOA | 2022-08-23T15:46:11Z | |
| html.description.abstract | <p>The Food and Drug Administration’s (FDA) Mini-Sentinel is a pilot program that aims to conduct active surveillance to detect and refine safety signals that emerge for marketed medical products.</p> <p>The purpose of this Mini-Sentinel AMI Validation project was to:</p> <p>(a) develop and design an abstraction and adjudication process to use when full text medical record review is required to confirm a coded diagnosis; and</p> <p>(b) to test this approach by validating a code algorithm for acute myocardial infarction (AMI).</p> | |
| dc.identifier.submissionpath | cts_retreat/2011/posters/2 |

